University Hospitals of Morecambe Bay NHS Foundation Trust is an NHS Foundation Trust in North West England, providing services in South Cumbria and North Lancashire in the Morecambe Bay area. It has about 6,000 employees and provides services for some 350,000 people.

During the past decade, University Hospitals of Morecambe Bay NHS Foundation Trust conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospitals of Morecambe Bay NHS Foundation Trust" #1 sponsor was "South Tyneside and Sunderland NHS Foundation Trust" with 2 trials, followed by "Brynn Chappell" with 1 trials sponsored, "Clovis Oncology, Inc." with 1 trials sponsored, "Prostate Cancer Clinical Trials Consortium" with 1 trials sponsored and "Queen's University, Belfast" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospitals of Morecambe Bay NHS Foundation Trust" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Cardiff and Vale University Health Board" with 2 trials as a collaborator, "NHS Lothian" with 2 trials as a collaborator, "ARC Medical Design Ltd" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 54 trials.

According to Clinical.Site data, the most researched conditions in "University Hospitals of Morecambe Bay NHS Foundation Trust" are "Colonic Polyp" (2 trials), "Mesothelioma" (2 trials), "Acute Respiratory Illnesses" (1 trials), "Adenoma" (1 trials) and "Bronchiectasis" (1 trials). Many other conditions were trialed in "University Hospitals of Morecambe Bay NHS Foundation Trust" in a lesser frequency.

Most popular intervention types in "University Hospitals of Morecambe Bay NHS Foundation Trust" are "Drug" (6 trials), "Other" (3 trials), "Device" (2 trials), "Diagnostic Test" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Nivolumab" (2 trials), "AZD5363" (1 trials), "Carboplatin" (1 trials) and "Chloroquine or Hydroxychloroquine" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospitals of Morecambe Bay NHS Foundation Trust" are 9 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University Hospitals of Morecambe Bay NHS Foundation Trust". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in University Hospitals of Morecambe Bay NHS Foundation Trust, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospitals of Morecambe Bay NHS Foundation Trust, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".